Back to Main

Faculty Detail    
Name CAROLINE MARSHALL
 
Campus Address THT 638C Zip 0007
Phone 205-975-2021
E-mail cmars@uab.edu
Other websites
      ICM Preceptor


Faculty Appointment(s)
Appointment Type Department Division Rank
Primary  Medicine  Med - Nephrology Assistant Professor

Biographical Sketch 
Dr. Marshall received her medical degree from Baylor College of Medicine in Houston, Texas, in 1999. Subsequently, she completed internship and residency training in Internal Medicine at Baylor College of Medicine Affiliated Hospitals in 2002. Thereafter, at the University of Washington School of Medicine in Seattle, Washington, she completed a clinical and research fellowship in Nephrology.

In 2006, Dr. Marshall joined the Division of Nephrology faculty at the University of Washington Medical Center (UWMC) as Acting Instructor. In 2007, she was promoted to Assistant Professor of Medicine at UWMC. In 2011, Dr. Marshall joined the UAB Department of Medicine, Division of Nephrology.

Society Memberships
Organization Name Position Held Org Link
American Society of Nephrology     

Research/Clinical Interest
Title
Biology of glomerular visceral epithelial cells (podocytes) in health and disease
Description
The role of podocyte injury in the initiation and progression of glomerulosclerosis. The role of cell cycle regulatory proteins in podocyte response to injury, with a particular focus on DNA damage and apoptosis. The transdifferentiation of podocytes into a dysregulated phenotype in response to stress, adopting a smooth muscle cell-like phenotype. The role of podocyte injury in the pathogenesis of early diabetic nephropathy.

Selected Publications 
Publication PUBMEDID
1. Wada T, Pippin JW, Marshall CB, Griffin SV, Shankland SJ. Dexamethasone Prevents Podocyte Apoptosis Induced by Puromycin Aminonucleoside: Role of p53 and Bcl-2-related Family Proteins. J Am Soc Nephrol 2005; 16: 2615-2625.

2. Marshall CB, Shankland SJ. Cell Cycle and Glomerular Disease: A Minireview. Nephron Exp Nephrol 2006; 102 (2): e39-e48. Epub 2005 Sep 21.

3. Marshall CB, Pippin JW, Krofft RD, Shankland SJ. Puromycin Aminonucleoside Induces Oxidant-Dependent DNA Damage In Vitro and In Vivo. Kidney International, 2006; 70 (11): 1962-1973.

4. Marshall CB, Shankland SJ. Cell Cycle Regulatory Proteins in Podocyte Health and Disease. Nephron Exp Nephrol, 2007; 106 (2): e51-9. Epub 2007 Jun 6.

5. Pippin JW, Brinkkoetter PT, Cormack-Aboud FC, Durvasula RV, Hauser PV, Kowalewska J, Krofft RD, Logar CM, Marshall CB, Ohse T, Shankland SJ. Inducible rodent models of acquired podocyte diseases. Am J Physiol Renal Physiol. 2009 Feb; 296 (2): F213-29.

6. Ohse T, Vaughan MR, Kopp JB, Krofft RD, Marshall CB, Chang AM, Hudkins KL, Alpers, CE, Pippin JW, Shankland SJ. De novo Expression of Podocyte Proteins in Parietal Epithelial Cells During Experimental Glomerular Disease. Am J Physiol Renal Physiol. Epub 2009 Dec 09.

7. Marshall CB, Krofft RD, Pippin JW, Shankland SJ. The CDK-inhibitor p21 is Pro-survival in Adriamycin-Induced Podocyte Injury, in vitro and in vivo. Am J Physiol Renal Physiol. Epub 2010 Feb 03.

8. Marshall CB, Krofft RD, Blonski MJ, Kowalewska J, Logar CM, Pippin JW, Kim F, Feil R, Alpers CE, Shankland SJ. The Role of Smooth Muscle Protein SM22-alpha; in Glomerular Epithelial Cell Injury. Am J Physiol Renal Physiol. Epub 2011 Feb 02.

9. Chugh SS, Macé C, Clement LC, Del Nogal Avila M, and Marshall CB. Angiopoietin-like-4 based therapeutics for proteinuria and kidney disease. Frontiers in Pharmacology. Epub 2014 Feb 14.